Hrt Financial LP I Mab Transaction History

Hrt Financial LP

  • $15.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$1.21 - $1.9 $20,998 - $32,972
17,354 New
17,354 $32,000
Q4 2022

Feb 10, 2023
BUY
$3.22 - $4.86 $121,526 - $183,421
37,741 New
37,741 $157,000
Q2 2022

Aug 12, 2022
BUY
$8.27 - $18.43 $381,734 - $850,710
46,159 New
46,159 $521,000

Others Institutions Holding IMAB

# of Institutions
45
Shares Held
16M
Call Options Held
11.9K
Put Options Held
3.5K
View Full List

About I-Mab

IMAB Quotes by TradingView
  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $131M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email